The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis
|
journal
|
March 1968 |
Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.
|
journal
|
September 1985 |
Injectable Paromomycin for Visceral Leishmaniasis in India
|
journal
|
June 2007 |
Leishmaniasis: an update of current pharmacotherapy
|
journal
|
December 2012 |
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
|
journal
|
February 2011 |
In VivoInterference of Paromomycin with Mitochondrial Activity ofLeishmania
|
journal
|
May 1997 |
Differential Effects of Paromomycin on Ribosomes of Leishmania mexicana and Mammalian Cells
|
journal
|
October 2010 |
Genetic Reconstruction of Protozoan rRNA Decoding Sites Provides a Rationale for Paromomycin Activity against Leishmania and Trypanosoma
|
journal
|
May 2011 |
Identification of the molecular attributes required for aminoglycoside activity against Leishmania
|
journal
|
July 2013 |
Increased Selectivity toward Cytoplasmic versus Mitochondrial Ribosome Confers Improved Efficiency of Synthetic Aminoglycosides in Fixing Damaged Genes: A Strategy for Treatment of Genetic Diseases Caused by Nonsense Mutations
|
journal
|
November 2012 |
Differential Selectivity of Natural and Synthetic Aminoglycosides towards the Eukaryotic and Prokaryotic Decoding A Sites
|
journal
|
September 2007 |
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations
|
journal
|
December 2006 |
Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
|
journal
|
May 2009 |
Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
|
journal
|
June 2010 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
|
journal
|
January 2009 |
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
|
journal
|
December 2009 |
Antibacterial Aminoglycosides with a Modified Mode of Binding to the Ribosomal-RNA Decoding Site
|
journal
|
December 2004 |
Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding
|
journal
|
September 2005 |
Apramycin recognition by the human ribosomal decoding site
|
journal
|
May 2007 |
Crystallographic studies of Homo sapiens ribosomal decoding A site complexed with aminoglycosides
|
journal
|
September 2005 |
Crystal Structure of theHomo sapiens Cytoplasmic Ribosomal Decoding Site Complexed with Apramycin
|
journal
|
May 2006 |
Crystal Structure of the Bacterial Ribosomal Decoding Site Complexed with a Synthetic Doubly Functionalized Paromomycin Derivative: a New Specific Binding Mode to an A-Minor Motif Enhances in vitro Antibacterial Activity
|
journal
|
November 2007 |
Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics
|
journal
|
September 2000 |
Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit
|
journal
|
May 2001 |
Selection of tRNA by the Ribosome Requires a Transition from an Open to a Closed Form
|
journal
|
November 2002 |
Structural Insights into Translational Fidelity
|
journal
|
June 2005 |
Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site
|
journal
|
January 2006 |
The bacterial and mitochondrial ribosomal A-site molecular switches possess different conformational substates
|
journal
|
March 2008 |
Novel Paromamine Derivatives Exploring Shallow-Groove Recognition of Ribosomal- Decoding-Site RNA
|
journal
|
December 2002 |
Structural basis for the inhibition of the eukaryotic ribosome
|
journal
|
September 2014 |
Crystal Structures of a Bioactive 6′-Hydroxy Variant of Sisomicin Bound to the Bacterial and Protozoal Ribosomal Decoding Sites
|
journal
|
February 2013 |
Toxicity Modulation, Resistance Enzyme Evasion, and A-Site X-ray Structure of Broad-Spectrum Antibacterial Neomycin Analogs
|
journal
|
July 2014 |
Inhibition of Aminoglycoside-Deactivating Enzymes APH(3′)-IIIa and AAC(6′)-Ii by Amphiphilic Paromomycin O2′′-Ether Analogues
|
journal
|
September 2011 |
A Structural Basis for the Antibiotic Resistance Conferred by an A1408G Mutation in 16S rRNA and for the Antiprotozoal Activity of Aminoglycosides
|
journal
|
November 2011 |
Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity: A STRATEGY FOR THE TREATMENT OF GENETIC DISEASES
|
journal
|
December 2013 |
Paromomycin: Uptake and resistance in Leishmania donovani
|
journal
|
April 2009 |
Aminoglycoside Antibiotics
|
journal
|
January 2000 |
Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up
|
journal
|
November 2007 |
Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity
|
journal
|
December 2008 |
Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin
|
journal
|
June 2012 |
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
|
journal
|
June 2012 |
Novel Paromamine Derivatives Exploring Shallow-Groove Recognition of Ribosomal-Decoding-Site RNA.
|
journal
|
February 2003 |
Ribosomes ofLeishmania are a target for the aminoglycosides
|
journal
|
January 1995 |
Crystal Structure of Geneticin Bound to a Bacterial 16S Ribosomal RNA A Site Oligonucleotide
|
journal
|
February 2003 |
Combination therapy for visceral leishmaniasis
|
journal
|
February 2011 |
Crystal Structure of Paromomycin Docked into the Eubacterial Ribosomal Decoding A Site
|
journal
|
August 2001 |
Crystal Structure of a Complex between the Aminoglycoside Tobramycin and an Oligonucleotide Containing the Ribosomal Decoding A Site
|
journal
|
June 2002 |
Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
|
journal
|
February 2013 |
Taking a Bite Out of Vector-Transmitted Infectious Diseases
|
journal
|
June 2007 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
XDS
|
journal
|
January 2010 |
A Highly Efficient 24-Condition Matrix for the Crystallization of Nucleic Acid Fragments
|
journal
|
May 1996 |
Early Curative Applications of the Aminoglycoside WR279396 on an Experimental Leishmania major-Loaded Cutaneous Site Do Not Impair the Acquisition of Immunity
|
journal
|
December 2009 |
Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
|
journal
|
April 2014 |
Comment on: Leishmaniasis: an update of current pharmacotherapy
|
journal
|
April 2013 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
Genetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and Trypanosoma
|
text
|
January 2011 |
Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity
|
text
|
January 2008 |